MOUNTAIN VIEW, Calif.,
Feb. 2, 2017 /PRNewswire/ --
Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and
supply management solutions and analytics software for healthcare
facilities, will hold a conference call Wednesday, February 15, 2017, to discuss the
Company's fourth Quarter 2016 financial results.
|
What:
|
Omnicell Fourth
Quarter 2016 earnings conference call and webcast
|
|
When:
|
February 15, 2017,
1:30 p.m. PT
|
|
Who:
|
Randall Lipps,
chairman, president and chief executive officer
|
|
Peter Kuipers, chief
financial officer
|
|
Where:
|
The conference call
can be monitored by dialing 1-800-696-5518 within the U.S. or
1-706-758-4883 for all other locations. The Conference ID # is
36561632. The webcast can be accessed at:
http://ir.omnicell.com/events.cfm.
|
|
|
|
How:
|
Link to the Omnicell
website 15 minutes prior to the call to download necessary audio
software.
|
|
Replay:
|
Available starting at
4:30 p.m. PT on February 15, 2017 through 11:59 p.m. PT on March
29, 2017. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406
for all other locations, Conference ID # 36561632.
|
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create
safer and more efficient ways to manage medications and supplies
across all care settings. As a leader in medication and supply
dispensing automation, central pharmacy automation, IV robotics,
analytics software, and medication adherence and packaging systems,
Omnicell is focused on improving care across the entire healthcare
continuum—from the acute care hospital setting, to post-acute
skilled nursing and long-term care facilities, to the patient's
home.
Over 4,000 customers worldwide use Omnicell®
automation and analytics solutions to increase operational
efficiency, reduce medication errors, deliver actionable
intelligence and improve patient safety.
The Omnicell SureMed® solution provides innovative
medication adherence packaging to help reduce costly hospital
readmissions. These medication adherence solutions are used by over
32,000 institutional and retail pharmacies in North America and the United Kingdom. These pharmacies are
served via Omnicell's sales channels and our solutions enable them
to maintain high accuracy and quality standards in medication
dispensing and administration while optimizing productivity and
controlling costs.
Recent acquisitions, including Ateb, have added distinct
capabilities, particularly in central pharmacy, IV robotics and
pharmacy software, creating the broadest medication management
product portfolio in the industry.
For more information about Omnicell, Inc. please visit
www.omnicell.com.
OMCL-E
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omnicell-to-release-fourth-quarter-2016-earnings-results-on-february-15th-300400560.html
SOURCE Omnicell, Inc.